Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
LORATADINE
Merck Sharp & Dohme Ireland (Human Health) Limited
LORATADINE
10 Milligram
Tablets
Product not subject to medical prescription
Authorised
0000-00-00
PACKAGE LEAFLET: INFORMATION FOR THE USER CLARITYN 10 MG TABLETS Loratadine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist, or nurse has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. - You must talk to a doctor if you do not feel better or if you feel worse. See section 4. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Clarityn is and what it is used for 2. What you need to know before you take Clarityn 3. How to take Clarityn 4. Possible side effects 5. How to store Clarityn 6. Contents of the pack and other information 1. WHAT CLARITYN IS AND WHAT IT IS USED FOR The full name of your medicine is Clarityn tablets. WHAT CLARITYN IS Clarityn tablets contain the active substance loratadine which belongs to a class of medicines called “antihistamines”. HOW CLARITYN WORKS Clarityn helps to re Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clarityn 10 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10mg loratadine. Excipients with known effect: The quantity of lactose monohydrate in the loratadine 10mg tablet composition is 71.3mg. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet White to off-white, oval tablet with flask and bowl, score and ‘10’ on one side and plain on the other side. The score line of the tablet is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clarityn is indicated for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children over the age of 2 years with a body weight more than 30 kg_._ 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults and children over 12 years of age: 10 mg once daily (one tablet once daily). _Paediatric population_ Children 2 to 12 years of age are dosed by weight: Body weight more than 30 kg: 10 mg once daily (one tablet once daily). Body weight 30 kg or less: The 10 mg strength tablet is not appropriate in children with a body weight less than 30 kg. There are other formulations more suitable for children 2 to 12 years old with body weight 30 kg or less. THE SAFETY AND EFFICACY OF CLARITYN IN CHILDREN UNDER 2 YEARS OF AGE HAVE NOT BEEN ESTABLISHED. NO DATA ARE AVAILABLE. _Patients with hepatic impairment_ Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10 mg every other day is recommended for adults and children weighing more than 30 kg. _Patients with renal impairment_ N Read the complete document